Innovative Eyewear (LUCY) 10% owner Galkin reports major stock trades

Rhea-AI Filing Summary

Innovative Eyewear Inc. 10% owner Vladimir Galkin reported recent trades in the company’s common stock. On January 2, 2026, he reported purchasing 4,000 shares of common stock at a volume‑weighted average price of $1.02 per share, bringing reported beneficial ownership to 643,505 shares.

On January 7, 2026, he reported an additional transaction of 643,505 shares at a volume‑weighted average price of $1.79 per share, after which the table shows 0 shares beneficially owned. The filing notes that these shares are held jointly by Vladimir and Angelica Galkin as husband and wife, and that prices are volume‑weighted averages that include commissions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galkin Vladimir

(Last) (First) (Middle)

10900 N.W. 97TH. STREET, SUITE #102

(Street)

MIAMI FL 33178

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.00001	01/02/2026		P		4,000	D	$1.02(1)	643,505	D(2)
Common Stock, par value $0.00001	01/07/2026		P		643,505	D	$1.79(1)	0	D(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The prices reported are volume weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased or sold in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased or sold at each price.

2. The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

	Vladimir Galkin, Attorney in Fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who reported transactions in Innovative Eyewear (LUCY) stock?

The filing reports transactions by Vladimir Galkin, identified as a 10% owner of Innovative Eyewear Inc.

What transactions did Vladimir Galkin report in Innovative Eyewear (LUCY) shares?

He reported non‑derivative transactions in common stock with transaction code P, indicating purchases, on January 2, 2026 and January 7, 2026.

How many Innovative Eyewear shares did Galkin trade and at what prices?

On January 2, 2026, he reported 4,000 shares at a volume‑weighted average price of $1.02 per share. On January 7, 2026, he reported 643,505 shares at a volume‑weighted average price of $1.79 per share.

How many Innovative Eyewear shares were beneficially owned after these transactions?

After the January 2, 2026 transaction, the table shows 643,505 shares beneficially owned. After the January 7, 2026 transaction, it shows 0 shares beneficially owned.

How are the Innovative Eyewear shares held by Vladimir Galkin structured?

A footnote explains that the shares of common stock are held jointly by Vladimir Galkin and Angelica Galkin, who are husband and wife.

What do the footnotes say about the reported share prices in the Innovative Eyewear Form 4?

The footnotes state that the reported prices are volume weighted‑average prices that include commissions, and that the shares were bought or sold in multiple transactions.